eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

ViiV Healthcare UK Ltd

Stockley Park West, Uxbridge, Middlesex,, UB11 1BT, UK
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 10/11/2011
PIL Kivexa film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 10/11/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 23/05/2011 and displayed until 10/11/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 21/10/2010 and displayed until 23/05/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 01/09/2010 and displayed until 21/10/2010
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
  • Change to manufacturer contact details
Updated on 11/02/2010 and displayed until 01/09/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
  • Change to information about pregnancy or lactation
Updated on 15/12/2009 and displayed until 11/02/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 19/06/2009 and displayed until 15/12/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 23/04/2008 and displayed until 19/06/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 01/03/2007 and displayed until 23/04/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 05/01/2005 and displayed until 01/03/2007
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   lamivudine
   abacavir sulfate